CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Open
4 Mar, 20:20
NYSE NYSE
$
80. 83
+0.34
+0.42%
$
96.93B Market Cap
11.4 P/E Ratio
0.97% Div Yield
3,515,407 Volume
7.87 Eps
$ 80.49
Previous Close
Day Range
79.67 80.98
Year Range
58.35 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS earnings report is expected in 56 days (29 Apr 2026)
CVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)

CVS Health Corporation (CVS) Wolfe 2024 Healthcare Conference (Transcript)

CVS Health Corporation (NYSE:CVS ) Wolfe 2024 Healthcare Results Conference November 19, 2024 10:20 AM ET Company Participants Tom Cowhey - Executive Vice President, Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Research Justin Lake Got to mention Larry McGrath, the head of strategy in IR refused to sit up here with us, but he's doing God's work for the company, and we all appreciate it. Thank you, Larry.

Seekingalpha | 1 year ago
CVS Health Taps Physician To Lead Healthcare Delivery Business

CVS Health Taps Physician To Lead Healthcare Delivery Business

CVS Health elevated Dr. Sreekanth Chaguturu to lead the company's healthcare delivery business a year after the company spent more than $20 billion on homecare provider Signify Health and senior clinic operator Oak Street Health.

Forbes | 1 year ago
Glenview Capital CEO Larry Robbins on the deal for new CVS Health board seats

Glenview Capital CEO Larry Robbins on the deal for new CVS Health board seats

Larry Robbins, Glenview Capital Management CEO, joins CNBC's 'Squawk on the Street' to discuss his firm's four new seats on the board at CVS, how the company can recover after a long decline, and more.

Youtube | 1 year ago
CVS Health adds four new board members in deal with Glenview Capital

CVS Health adds four new board members in deal with Glenview Capital

CNBC's David Faber reports on news from CVS.

Youtube | 1 year ago
CVS Health Adds Four Board Seats In Deal With Hedge Fund

CVS Health Adds Four Board Seats In Deal With Hedge Fund

CVS Health Monday said four new members will be added to its board from the hedge fund Glenview Capital Management, an activist investor that had been pushing for changes at the diversified healthcare giant.

Forbes | 1 year ago
CVS strikes deal with activist Glenview Capital for four board seats

CVS strikes deal with activist Glenview Capital for four board seats

CVS Health struck a deal with dissident Glenview Capital giving the investor four board seats. Glenview had been pushing for changes at the healthcare giant and had met with former CEO Karen Lynch prior to her ouster.

Cnbc | 1 year ago
CVS Health gains as board grows on deak with activist investor Glenview

CVS Health gains as board grows on deak with activist investor Glenview

CVS Health Corp (NYSE:CVS) ticked up in pre-market trading after announcing the addition of four board members as part of a deal with activist investor Glenview Capital Management.  Larry Robbins, chief executive of the hedge fund, will join CVS' board, alongside Leslie Norwalk, Guy Sansone, and Doug Shulman, leaving the company with 16 directors.

Proactiveinvestors | 1 year ago
CVS Adds 4 New Board Members After Activist Push

CVS Adds 4 New Board Members After Activist Push

Hedge fund Glenview Capital Management has been advocating for improvements at the pharmacy and healthcare company.

Barrons | 1 year ago
CVS adds four new board members in deal with Glenview Capital

CVS adds four new board members in deal with Glenview Capital

CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins.

Reuters | 1 year ago
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings

Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third quarter, according to regulatory filings.

Reuters | 1 year ago
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Estimates for CVS Southbound After Rocky Q3: How to Play the Stock

Estimates for CVS Southbound After Rocky Q3: How to Play the Stock

CVS Health expects the elevated levels of utilization to continue to put pressure on its 2024 performance and as a result could not provide an outlook for 2024.

Zacks | 1 year ago
Loading...
Load More